Orion quarterly operating profit jumps

HELSINKI Tue Oct 23, 2012 5:19am EDT

HELSINKI (Reuters) - Finnish drug maker Orion (ORNBV.HE) reported a 17 percent rise in quarterly operating profit, managing to make up for a fall in sales of its Stalevo drug for Parkinson's disease with other products.

Orion said its third-quarter operating profit rose to 76.3 million euros from 65.3 million euros a year earlier.

Generic competitors dented sales of its Stalevo drug in the United States, but this was offset by compensation from Novartis (NOVN.VX) and sales of other drugs, the company said.

(Reporting by Helsinki newsroom)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.